Skip to main content

Soligenix, Inc.

SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000812796

No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Soligenix, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of SNGX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders1811−7
Shares239.1K100.4K−138.7K (−58.0%)
Value$143.0K$259.1K+$116.2K (+81.2%)

New holders (4)

Institutions that held Soligenix, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SNGX in Q2 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC80,000$206.4K0.01%
Old National Bancorp10,000$25.8K0.00%
FMR LLC1$30.00%
Trust Co of Vermont1$30.00%

Sold out (11)

Institutions that held Soligenix, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of SNGX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Geode Capital Management, LLC56,799$34.1K
Vanguard Group Inc50,865$30.5K
Nomura Holdings Inc30,000$18.0K
Warberg Asset Management LLC24,500$14.7K
First Wilshire Securities Management Inc23,334$14.0K
Two Sigma Investments, LP12,731$7.64K
HRT Financial LP12,518$7.00K
Two Sigma Securities, LLC11,435$6.86K
Advisor Group Holdings, Inc.53$32
Brown Brothers Harriman & Co34$20
GWM Advisors LLC3$2